More articles from Clinical Problems COPD

Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD
Fernando J. Martinez, Klaus Rabe, Peter Calverley, Leonardo Fabbri, Sanjay Sethi, Emilio Pizzichini, Andrew McIvor, Antonio Anzueto, Vijay Alagappan, Shahid Siddiqui, Colin Reisner, Debasree Purkayastha, Jonas Roman, Stephen Rennard

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4962; DOI: 10.1183/1393003.congress-2017.PA4962
Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD
Ernesto Crisafulli, Mónica Guerrero, Antonella Ielpo, Arturo Huerta, Albert Gabarrús, Néstor Soler, Alfredo Chetta, Antoni Torres

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4959; DOI: 10.1183/1393003.congress-2017.PA4959
Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients
Chiung-Zuei Chen, Tang-Hsiu Hua, Meng-Zhi Han, Sheng-Han Tsai, Tzuen-Ren Hsiue

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4957; DOI: 10.1183/1393003.congress-2017.PA4957
Evaluation of roflumilast in COPD patients in a real-world European setting: results from the PROFILE EU study
Claus Vogelmeier, Nikolaos Tzanakis, Stefan Lassan, Eduardo Genofre, Bo Ding, John Horton, Per Bakke

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4960; DOI: 10.1183/1393003.congress-2017.PA4960
A real world experience of COPD exacerbations and possible association with Bronchiectasis in a medium size teaching hospital in the northwest of England
Himanshu Singh, Shahul Khan, Jack Murrell

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4966; DOI: 10.1183/1393003.congress-2017.PA4966
Impact of comorbid bronchiectasis on COPD patients
Ahmed Ben Saad, Samah Joobeur, Nesrine Fahem, Saoussen Cheikh Mhamed, Hadhami Mribah, Naceur Rouatbi, Ali El Kamel

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4955; DOI: 10.1183/1393003.congress-2017.PA4955
Use of the Daily PROactive instrument to evaluate physical activity in patients with COPD: results from ACTIVATE
Judith Garcia Aymerich, Henrik Watz, Kai M Beeh, Pierluigi Paggiaro, Miguel Moya, Massimo Notari, Diana Jarreta, Esther Garcia Gil, Thierry Troosters

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4964; DOI: 10.1183/1393003.congress-2017.PA4964
Elevated systemic biomarkers and persistent anxiety and depression in smokers with and without COPD: An analysis of the SPIROMICS cohort
Victor Kim, Huaqing Zhao, Hilary Armstrong, Wanda O'Neal, Kristina Bailey, Stephen Rennard, R. Graham Barr, Gerard Criner, Gina Lovasi, Mary Morrison

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4967; DOI: 10.1183/1393003.congress-2017.PA4967
Population-based analysis of COPD patients in Catalonia: implications for case management
Erik Baltaxe, Josep Roca, Emili Vela, Akos Tenyi, Isaac Cano, David Monterde, Montse Claries, Anna Garcia-Altes, Carme Hernandez, Joan Escarrabill

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4956; DOI: 10.1183/1393003.congress-2017.PA4956
Determining SGRQ and TDI responder rates across the duration of clinical trials: Results from tiotropium + olodaterol in COPD
Eric Derom, Henrik Watz, Lars Grönke, Florian Voss, Roland Buhl

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4958; DOI: 10.1183/1393003.congress-2017.PA4958

Main menu

User menu

Search

More articles from Clinical Problems COPD

Pages

Contact us